Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients

Figure 3

Serum values of galectin-3 and ratio of galectin-3 and proinflammatory and immunosupressive cytokines. Galectin-3 was analyzed in all four groups of patients. Increased level of galectin-3 in ESRD patients compared to the healthy control as well as significantly increased level of galectin-3 in ESRD HCV⁺ patients in comparison to HCV⁺ patients. Serum level of galectin-3 was determined by ELISA.